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Abstract. 
 
In polarized HepG2 cells, the fluorescent 
 
sphingolipid analogues of glucosylceramide (C
 
6
 
-NBD-
GlcCer) and sphingomyelin (C
 
6
 
-NBD-SM) display a 
preferential localization at the apical and basolateral 
domain, respectively, which is expressed during apical 
to basolateral transcytosis of the lipids (van IJzen-
doorn, S.C.D., M.M.P. Zegers, J.W. Kok, and D. Hoek-
stra. 1997. 
 
J
 
.
 
 Cell Biol
 
. 137:347–457). In the present 
study we have identified a non-Golgi–related, sub-api-
cal compartment (SAC), in which sorting of the lipids 
occurs. Thus, in the apical to basolateral transcytotic 
pathway both C
 
6
 
-NBD-GlcCer and C
 
6
 
-NBD-SM accu-
 
mulate in SAC at 18
 
8
 
C. At this temperature, transcy-
tosing IgA also accumulates, and colocalizes with the 
lipids. Upon rewarming the cells to 37
 
8
 
C, the lipids are 
transported from the SAC to their preferred membrane 
domain. Kinetic evidence is presented that shows in a 
direct manner that after leaving SAC, sphingomyelin 
disappears from the apical region of the cell, whereas 
GlcCer is transferred to the apical, bile canalicular 
membrane. The sorting event is very specific, as the 
GlcCer epimer C
 
6
 
-NBD-galactosylceramide, like C
 
6
 
-
NBD-SM, is sorted in the SAC and directed to the ba-
solateral surface. It is demonstrated that transport of 
the lipids to and from SAC is accomplished by a vesicu-
lar mechanism, and is in part microtubule dependent. 
Furthermore, the SAC in HepG2 bear analogy to the 
apical recycling compartments, previously described in 
MDCK cells. However, in contrast to the latter, the 
structural integrity of SAC does not depend on an in-
tact microtubule system. Taken together, we have iden-
tified a non-Golgi–related compartment, acting as a 
“traffic center” in apical to basolateral trafficking and 
vice versa, and directing the polarized distribution of 
sphingolipids in hepatic cells.
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T
 
he
 
 plasma membrane (PM)
 
1
 
 of polarized cells is di-
vided into a basolateral and an apical PM domain.
Each membrane domain has its specific protein and
lipid composition, an essential feature for the polarized
function of these cells. To generate and maintain such
unique membrane compositions, proteins and lipids have
to be sorted and targeted to the appropriate PM domains.
In polarized cells apical delivery may occur via two routes,
including a direct transport from the TGN, and an indirect
pathway, in which before apical delivery, newly synthe-
sized components are first transported from the TGN to
the basolateral surface. Subsequently, apical constituents
are endocytosed, sorted into transcytotic vesicles, and
transported to the apical pole of the cell. To add to the
complexity of trafficking in polarized cells, proteins, and
lipids from each membrane domain are continuously rein-
ternalized, recycled, or redistributed, reflecting a dynamic
equilibrium indispensable for maintaining a dynamic
membrane composition capable of adapting to different
needs. As a consequence, apical (and basolateral) compo-
nents must be sorted into or excluded from vesicles with
preferential targets at various intracellular sites, each site
thus contributing to the polarized distribution of PM com-
ponents.
For both proteins and distinct (glyco)sphingolipids, the
main intracellular sorting site for polarized transport is be-
lieved to be the TGN. Specifically, in this compartment,
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several apical proteins appear to associate with glyco-
sphingolipid (GSL)-enriched domains (Brown and Rose,
1992), so-called GSL rafts (Simons and Ikonen, 1997).
Budding of these rafts will give rise to vesicles, with an
apical destination (Simons and Wandinger-Ness, 1990).
Whereas MDCK cells predominantly use the direct path-
way for the delivery of apical components (Matlin and Si-
mons, 1984; Misek et al., 1984; Pfeiffer et al., 1985; Simons
and Fuller, 1985), other polarized cells may use a combina-
tion of the direct and the indirect, transcytotic pathway
(van’t Hof and van Meer, 1990; Weimbs et al., 1997). He-
patic cells are believed to rely mainly on the indirect, trans-
cytotic pathway for the apical delivery of newly synthe-
sized proteins (Bartles et al., 1987; Cariappa and Kilberg,
1992; Schell et al., 1992), although evidence is accumulat-
ing which indicates that direct Golgi to apical transport of
proteins and lipids also occurs (Ali and Evans, 1990; Zaal
et al., 1993; Zegers and Hoekstra, 1997). The overall
mechanism involved in the apical flow of proteins and lip-
ids via the indirect, transcytotic route is still largely un-
clear. For example, whether GSL-rafting plays a role in
this route remains to be determined.
To study transcytosis, the polymeric immunoglobulin re-
ceptor (pIgR) and its ligand IgA is often used as a marker
of this pathway (Mostov and Deitcher, 1986; Apodaca et
al., 1991; Mostov et al., 1995). It has thus been demon-
strated that transcytosis proceeds along routes, which con-
stitute part of other pathways used by non-transcytosing
molecules. pIgR-IgA complexes, endocytosed from the
basolateral surface, are delivered to basolateral endo-
somes and reach via transcytosis sub-apical endosomal
compartments, termed apical recycling compartments
(ARC) in MDCK cells, before their delivery to the apical
PM (Apodaca et al., 1994; Barroso and Sztul, 1994). Other
apical proteins such as dipeptidyl peptidase IV and the
glycosylphosphatidylinositol-anchored protein 5
 
9
 
 nucleoti-
dase have been suggested to use the same transcytotic
pathway as pIgR–IgA (Barr et al., 1995). As revealed in
MDCK cells, the sub-apical compartments (SAC) are not
only accessible to proteins with a preference for apical lo-
calization. Also a considerable portion of the basolaterally
endocytosed transferrin receptor was found to be trans-
ported to the apical recycling compartment. However, in
contrast to the apically targeted pIgR-IgA, the transferrin
receptor returns to the basolateral surface (Apodaca et al.,
1994). Hence, these data suggest a role for the sub-apical
compartment in the generation and/or maintenance of the
polarized distribution of PM components.
Previous studies in MDCK (van Genderen and van
Meer, 1995) and the human hepatoma–derived cell line,
HepG2 (van IJzendoorn et al., 1997; Zegers and Hoekstra,
1997) revealed that sphingolipids such as glucosylceramide
(GlcCer) and sphingomyelin (SM) also use the transcy-
totic pathway to traverse the cell in either direction. How-
ever, very little is known of the mechanisms involved in
transcytotic transport of lipids. In a recent study, we dem-
onstrated that in well-polarized HepG2 cells fluorescent
acyl chain–labeled analogues of glucosylceramide (C
 
6
 
-
NBD-GlcCer) and sphingomyelin (C
 
6
 
-NBD-SM) are seg-
regated in the apical to basolateral transcytotic pathway
(van IJzendoorn et al., 1997). The observed segregation
event did not involve the Golgi apparatus, hinting at the
 
existence of another, yet unidentified subcellular compart-
ment where sphingolipids are sorted. In the present work
we provide evidence that SAC, similar to ARC as defined
in MDCK cells, are also operative in HepG2 cells. Specifi-
cally, it is demonstrated that these SAC represent the ma-
jor intracellular site in the transcytotic pathway where
GlcCer and SM are sorted and directed to distinct PM do-
mains.
 
Materials and Methods
 
Materials
 
Sphingosylphosphorylcholine, 1-
 
b
 
-glucosylsphingosine, cerebroside type
II, asialofetuin type I, and geneticin (G-418) were from Sigma Chemical
Co. (St. Louis, MO). Albumin (from bovine serum, fraction V) was
bought from Fluka Chemie AG (Buchs, Switzerland). 6-(
 
N
 
-[7-nitrobenz-
2-oxa-1,3-diazol-4-yl]amino) hexanoic acid (C
 
6
 
-NBD) was obtained from
Molecular Probes (Eugene, OR). DME was purchased from GIBCO-
BRL (Paisley, Scotland). FCS was bought from BioWhittaker (Verviers,
Belgium), and Na
 
2
 
S
 
2
 
O
 
4 
 
was from Merck (Darmstadt, Germany). Nocoda-
zole was obtained from Boehringer Mannheim (Mannheim, Germany).
PSC 833 and MK 571 were gifts from Dr. E. Vellenga (University of
Groningen, The Netherlands). Texas red–labeled IgA was kindly pro-
vided by Dr. K. Dunn (Indiana University Medical Center, Indianapolis,
IN). pIgR cDNA and an mAb against pIgR was kindly provided by Dr. K.
Mostov (University of California, San Francisco, CA). All other chemicals
were of analytical grade.
 
Cell Culture
 
HepG2 cells were grown at 37
 
8
 
C under a 5% CO
 
2
 
-containing, humidified
atmosphere in DME, supplemented with 10% heat-inactivated (at 56
 
8
 
C)
FCS, 2 mM 
 
l
 
-glutamine, 100 IU/ml penicillin, and 100 
 
m
 
g/ml streptomy-
cin. Medium was replaced every other day. For experiments, cells were
used 3 d after plating. At this time the cells had reached an optimal ratio
of polarity versus density, i.e., No. of bile canalicular spaces (BCs) versus
No. of cells.
 
Synthesis of C
 
6
 
-NBD–labeled Sphingolipids
 
C
 
6
 
-NBD-GlcCer and C
 
6
 
-NBD-SM were synthesized from C
 
6
 
-NBD and
1-
 
b
 
-glucosylsphingosine and sphingosylphosphorylcholine, respectively,
as described elsewhere (Kishimoto, 1975; Babia et al., 1994). 1-
 
b
 
-
 
d
 
-galac-
tosylceramide was prepared from cerebroside (type II) (Goda et al.,
1987). The C
 
6
 
-NBD-lipids were stored at 
 
2
 
20
 
8
 
C and routinely checked for
purity.
 
Cell Labeling and Lipid Transport Assays
 
For microscopy, cells were plated onto glass coverslips. For biochemical
analysis cells were cultured in 25-cm
 
2
 
 culture flasks (Costar, Cambridge,
UK). After 3 d, cells were washed three times with a PBS solution. C
 
6
 
-
NBD-GlcCer or C
 
6
 
-NBD-SM were dried under nitrogen, redissolved in
absolute ethanol, and then injected into HBSS under vigorous vortexing.
The final concentration of ethanol was kept below 0.5% (vol/vol). Cells
were incubated with 4 
 
m
 
M of either lipid analogue at 37
 
8
 
C for 30 min (see
Fig. 1, 
 
step 1
 
). To monitor transport of apical membrane–associated lipid
analogues, the basolateral pool of fluorescent lipid analogues was de-
pleted by incubating the cells in HBSS, supplemented with 5% (wt/vol)
BSA at 4
 
8
 
C twice for 30 min (back exchange, Fig. 1,
 
 step 2
 
). Then, cells
were washed three times with ice-cold PBS, rewarmed to the desired tem-
perature, and then incubated in HBSS, with 5% (wt/vol) BSA (Fig. 1, 
 
step
3
 
). The 18
 
8
 
C temperature block was dictated by previous observations in
MDCK cells showing that an incubation at this temperature causes a se-
lective inhibition of transcytotic transport, as revealed by the accumula-
tion of the transcytotic marker pIgA-R (Apodaca et al., 1994; Barosso and
Sztul, 1994). In some experiments, NBD fluorescence associated with BC
was eliminated by incubating the cells with 30 mM sodiumdithionite (di-
luted from a stock solution of 1 M Na
 
2
 
S
 
2
 
O
 
4
 
 in 1 M Tris, pH 10) at 4
 
8
 
C for 7
min (Fig. 1, 
 
step 4
 
). As described previously, sodiumdithionite is able to
pass the tight junctional complexes in HepG2 cells (van IJzendoorn et al., 
van IJzendoorn and Hoekstra 
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1997), whereas BSA does not affect the labeling of BC (see Results; com-
pare with van IJzendoorn et al., 1997). Sodiumdithionite-treated cells
were then washed extensively (
 
.
 
10 times) with ice-cold HBSS, after
which transport was re-activated by rewarming and further incubating the
cells in HBSS at 37
 
8
 
C (Fig. 1, 
 
step 5
 
). BSA (5% wt/vol) was included in the
medium to prevent the lipid analogues from re-entering the cells at the ba-
solateral surface. After all final incubations, cells were washed with ice-
cold HBSS and kept on ice until use (within 30 min).
To study the involvement of microtubules on transport of BC-associ-
ated lipids, nocodazole (33 
 
m
 
M, diluted from a 10 mM stock solution) was
added during step 2 of the incubation scheme depicted in Fig. 1 and kept
present in all subsequent steps. In parallel experiments, cells were treated
with 33 
 
m
 
M nocodazole at 4
 
8
 
C for 1 h after the 18
 
8
 
C chase of BC-associ-
ated lipid analogues (Fig. 1, 
 
step 3
 
). Indirect immunofluorescence, using a
mAb directed against ﬂ-tubulin (Sigma Chemical Co.), was performed to
verify the microtubule-disrupting potency of nocodazole in HepG2 cells
(not shown).
To study the effect of PSC 833 and MK 571, which are specific inhibi-
tors of the multi-drug resistance proteins MDR1/
 
P
 
-glycoprotein and
MRP1, respectively, on the different transport steps, cells were incubated
with MK 571 (25 
 
m
 
M) or PSC 833 (5 
 
m
 
g/ml) before step 1, with either in-
hibitor between steps 2 and 3, or between steps 4 and 5. The concentration
of PSC 833 was sufficient to completely block the excretion of rhodamine
123 into BC of HepG2 cells by MDR1/
 
P
 
-glycoprotein activity (not
shown).
 
Quantification of Fluorescent BC Labeling
 
As a measure for transport of the lipid analogues to and from the BC
membranes, the percentage of NBD-positive BC membranes was deter-
mined as described elsewhere (van IJzendoorn et al., 1997). In brief, BC
were first identified by phase contrast illumination, and then classified as
NBD-positive or NBD-negative under epifluorescence illumination. Fur-
thermore, distinct pools of fluorescence are discerned, present in vesicular
structures adjacent to BC, which in this work are defined as SAC. To-
gether, BC and SAC thus constitute the apical, bile canalicular pole
(BCP) in HepG2 cells. Therefore, within the BCP region the localization
of the fluorescent lipid analogues will be defined as being derived from
BC, SAC, or both. For this kind of quantification, at least 50 BCP were
analyzed per coverslip. All data are expressed as the mean 
 
6
 
 SD of four
independent experiments, carried out in duplicate.
 
Lipid Extraction and Quantification
 
Lipids were extracted according to the method of Bligh and Dyer (1959)
and analyzed by thin layer chromatography using CHCl
 
3
 
/methanol/
NH
 
4
 
OH/H
 
2
 
O (35:15:2:0.5, vol/vol/vol/vol) as running solvent. For quanti-
fication, fluorescent lipids were scraped from the TLC plates, followed by
vigorous shaking in 1% (vol/vol) Triton X-100 in H
 
2
 
O for 60 min to re-
move the lipids from the silica. Silica particles were then spun down and
NBD fluorescence was measured spectrophotometrically in an SLM fluo-
rometer at excitation and emission wavelengths of 465 nm and 530 nm, re-
spectively.
 
Transfection of HepG2 Cells with the pIgR
 
HepG2 cells were plated at low density (
 
6
 
20% confluency) in medium,
containing 20% FCS. Cells were allowed to attach and spread for 24 h.
The cells were then transfected with the cDNA encoding wild-type rabbit
pIgR, inserted into a pCB6 expression vector, which contained a neomy-
cin resistance marker. The synthetic pyridinium-based amphiphile
SAINT-2 (a gift from Saint BV, Groningen, The Netherlands) was used as
DNA carrier. Preparation of small unilamellar SAINT-2/dioleylphos-
phatidyl ethanolamine (DOPE) vesicles and transfection was performed
as described by van der Woude et al. (1997). Cells were selected in culture
media, supplemented with 600 
 
m
 
g/ml geneticin (G-418). Successful trans-
fection of HepG2 cells was evidenced by indirect immunofluorescence mi-
croscopy using a mAb against pIgR, and by the ability of the cells to inter-
nalize Texas red–labeled IgA (TxR-IgA) in the presence of a 100-fold
excess asialofetuin (see Results). The polarity of the transfected cells was
verified by determination of the ratio BC/cells (Zegers and Hoekstra,
1997).
 
Internalization of Texas Red–labeled IgA
 
Cells transfected with the pIgR as described above were washed and asia-
loglycoprotein receptors were saturated with excess asialofetuin at 37
 
8
 
C
for 30 min to prevent uptake of IgA via these receptors (see Results).
Cells were incubated with TxR-IgA (50 
 
m
 
g/ml) at 4
 
8
 
C for 30 min. Cells
were then washed to remove non-bound TxR-IgA and further incubated
at 18
 
8
 
, 37
 
8
 
C, or a combination of both for various time intervals, depend-
ing on the experiment.
 
Microscopical Analysis and Image Processing
 
Cells were examined microscopically using a conventional Olympus Pro-
vis AX70 fluorescence microscope. Photomicrographs were taken using
Illford HP5-plus films and scanned. For confocal laser scanning micros-
copy a TCS Leica (Heidelberg, Germany) apparatus equipped with a ar-
gon/krypton laser coupled to a Leitz DM IRB-inverted microscope was
used. All images were converted to tagged-information-file format before
printing on a Fujix P3000 printer.
 
Results
 
Apical Membrane–derived C
 
6
 
-NBD-GlcCer and
C
 
6
 
-NBD-SM Are Delivered to SAC
 
In a previous study we demonstrated that C
 
6
 
-NBD-GlcCer
and C
 
6
 
-NBD-SM display a preferential apical and basolat-
eral localization, respectively, in HepG2 cells. This prefer-
ential localization was established during apical to basolat-
eral transcytosis, a novel pathway in hepatic cells. A
tentative role for non-Golgi–related SAC in the apical re-
cycling of C
 
6
 
-NBD-GlcCer was proposed (van IJzendoorn
et al., 1997). However, neither the identity of these com-
partments nor their functional involvement in the apical to
basolateral transcytotic pathway of either lipid was estab-
lished. To address these issues, the following experiments
were performed.
Cells were labeled with 4 
 
m
 
M C
 
6
 
-NBD-SM or C
 
6
 
-NBD-
GlcCer at 37
 
8
 
C for 30 min. In this way, 
 
.
 
70% of the BC,
identified by phase-contrast microscopy, became labeled,
the lipid analogues thus becoming inserted into the canali-
cular membrane. In addition, fluorescently labeled vesicu-
lar structures are observed in the cytoplasm, presumably
representing compartments of the endocytic internaliza-
tion pathway and transport vesicles still en route to their
Figure 1. Schematic representation of the various steps of the
lipid transport assays. Cells are incubated with C6-NBD-lipids at
378C for 30 min, causing labeling of both apical (BC) and basolat-
eral membranes (step 1). Subsequently, the fraction of the fluo-
rescent lipid analogue residing at the basolateral PM is depleted
by BSA at 48C twice for 30 min (step 2). The BC-associated lipid
analogue is then chased into sub-apical compartments (see Re-
sults) at 188C for 1 h in BSA-containing medium (step 3). The
presence of BSA in the medium during this step will prevent re-
entry of any lipid analogue that might arrive basolaterally during
the chase. Next, the NBD-labeled lipid remaining at the BC is
quenched by sodiumdithonite (step 4), after which transport of
the sub-apically derived lipid analogue can be monitored upon
rewarming and incubating the cells at 378C (step 5). The vertical
bar in between each step represents wash steps. 
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target membranes. (Fig. 2, 
 
a
 
 and 
 
b
 
; compare with Fig. 2 in
van IJzendoorn et al., 1997). To subsequently monitor the
fate of the apical membrane–associated lipid analogues,
the basolateral pool was depleted by incubating the cells in
HBSS, supplemented with 5% BSA at 4
 
8
 
C twice for 30
min (back exchange). The cells were then washed, re-
warmed to either 18
 
8
 
 (see Materials and Methods) or 37
 
8
 
C,
and further incubated in HBSS, supplemented with 5%
BSA, for 60 min. At 18
 
8
 
C, basolateral delivery of the
lipid analogues, relative to that at 37
 
8
 
C, was inhibited by
 
z
 
70%, as calculated from the amount of C
 
6
 
-NBD-SM and
C
 
6
 
-NBD-GlcCer that could be retrieved in the BSA-con-
taining medium. Fluorescence microscopical analysis re-
vealed that upon chasing BC-associated lipid analogues
at 18
 
8
 
C, a major part of both C
 
6
 
-NBD-GlcCer and C
 
6
 
-
NBD-SM remained localized at the BCP of the cells, i.e.,
in BC and/or sub-apically located vesicular structures (Fig.
2, 
 
d
 
 and 
 
f
 
: 
 
thin arrows, BC; arrowheads, SAC). To reveal a
net directional movement of the lipid analogues in the
apical bile canalicular area, BCP labeling was distin-
guished into labeling of only BC, only SAC or labeling of
both BC and SAC. (See Materials and Methods, and Figs.
2, a [BC] and f [BC 1 SAC]; 4 b [SAC].) Such semi-quan-
titative analysis of labeling of the apical region revealed
that before the chase, .90% of the label detected in the
BCP region, was found to be solely associated with BC
(Fig. 3 A; see also the labeling pattern in Fig. 2, a and b).
Thus, the prominent labeling of sub-apical structures, as
revealed by accumulation of the lipid analogues, was not
observed before the chase at 188C was started (also com-
pare with van IJzendoorn et al., 1997). After the 188C
chase, the majority (685%) of the C6-NBD-GlcCer or C6-
NBD-SM present in the BCP was associated with both
SAC and BC (Fig. 3 B, BC 1 SAC and SAC), while only
z15% was due to the exclusive labeling of BC only (Fig. 3
B, BC). Also note that, for either lipid analogue, the per-
centage of labeled BCP did not change during the chase.
In conjunction with the fact that the presence of BSA in
the incubation medium prevented potential re-internaliza-
tion of the lipid analogues from the basolateral surface
and subsequent transport to the SAC, the data thus indi-
cate that the lipid analogues were transported via a direct
(i.e., basolateral membrane–independent) route from BC
to SAC.
Not all cells participate in the formation of BC (Zegers
and Hoekstra, 1997). Remarkably, however, also in cells
lacking a distinct apical PM domain a significant part of
the intracellular C6-NBD-GlcCer and C6-NBD-SM frac-
tions accumulated in juxtanuclear compartments after a
Figure 2. BC-derived C6-NBD-GlcCer and C6-NBD-SM accumu-
late in SAC at 188C. Cells were labeled with 4 mM C6-NBD-GlcCer
or C6-NBD-SM at 378C for 30 min. Subsequently, the fluorescent
lipid pool in the basolateral PM was removed by back exchange
(a, C6-NBD-SM; b, C6-NBD-GlcCer; arrows point to BC). Alter-
natively, the cells were subsequently washed and further incubated
at 188C for 60 min. C6-NBD-SM (c and d) and C6-NBD-GlcCer (e
and f) labeled the BCP of the cells, i.e., BC (thin arrows) and vesicu-
lar structures located near the BC membranes (arrowheads). In
cells that did not participate in the formation of BC some accumula-
tion of the fluorescent lipid analogue in juxtanuclear compart-
ments was often seen (f, wide arrows) (c and e, phase contrast to d
and f, respectively). Bar, 10 mm.
Figure 3. Semi-quantitative analysis
of BCP labeling: accumulation of
C6-NBD-lipid analogues in SAC.
Cells were labeled and treated as
depicted in Fig. 1. A represents the
distribution of NBD lipid in BC and
SAC after step 1 (30 min at 378C)
while the distribution indicated in B
was obtained after a subsequent
back exchange and chase from BC
at 188C for 60 min (Fig. 1, step 2
and 3). In both cases, the percent-
age C6-NBD-GlcCer- and C6-NBD-
SM-labeled BCP was z85%. Label-
ing of BCP was distinguished in
either NBD-positive BC only, a cellular BCP fraction in which both BC and SAC were labeled (BC 1 SAC), or NBD-positive SAC.
Data are expressed as percentage of the total number of C6-NBD-GlcCer– (white bars) and C6-NBD-SM–positive (hatched bars) BCP
(minimum of 50/coverslip; mean 6 SEM) of at least four independent experiments carried out in duplicate.van IJzendoorn and Hoekstra Sphingolipid Sorting in Sub-Apical Compartments 687
60-min incubation at 188C (Fig. 2 f, wide arrows), but not
at 378C (data not shown).
Finally, it is important to note that in the experiments at
both 188 and 378C, the only fluorescent lipid analogue
identified in the incubation media and cell fractions was
the one that was exogenously administered, indicating that
no metabolism of either lipid had occurred during the time
span of the experiments (data not shown). Taken together,
the data clearly demonstrate that low temperature (188C)
can selectively impede apical to basolateral transcytosis of
both C6-NBD-GlcCer and C6-NBD-SM. The observed
accumulation of the analogues in the same subcellular
compartments (SAC) located adjacent to the BC mem-
brane, indicates that at least early in the trafficking path-
way during apical to basolateral transcytosis, both C6-
NBD-GlcCer and C6-NBD-SM pass through the same
compartments, while before their arrival in SAC, signifi-
cant sorting, proceeding their preferential rerouting to apical
and basolateral region, respectively, has not yet occurred.
The latter is supported by the striking similarity in semi-
quantitative distribution of the two analogues (Fig. 3 B).
C6-NBD-SM and C6-NBD-GlcCer Flow from SAC to 
Distinct PM Domains
Since GlcCer and SM display a distinct preferential local-
ization within the cell, we next examined the possibility as
to whether the compartments identified as SAC by accu-
mulation of either lipid analogue, were functionally in-
volved in redirecting their trafficking. Hence, to address
the issue of SAC acting as a sorting compartment, the cells
were labeled with C6-NBD-GlcCer or C6-NBD-SM, simi-
larly as described above. After chasing the lipid analogues
into SAC at 188C, NBD fluorescence still present in the
BC was irreversibly abolished by incubating the cells with
30 mM sodiumdithionite at 48C for 10 min (Fig. 4; see Ma-
terials and Methods). After treatment, z80–90% of the
identified BCP was still fluorescently labeled (Fig. 5 A),
but ,10% of the total fluorescence (C6-NBD-GlcCer or
C6-NBD-SM) located in the bile canalicular area after
dithionite quenching, was due to labeling of BC (Fig. 5,
B and C, 0 min; for fluorescence images compare Fig. 4,
b/d vs. Fig. 2, b/d). Indeed, dithionite effectively abolishes
NBD fluorescence appearing at the luminal surface of the
bile canalicular space, while it does not gain access to in-
tracellular sites at the conditions of the treatment (van
IJzendoorn et al., 1997). Consequently, labeling with the
lipid analogues was predominantly in SAC alone (Fig. 4),
representing  .80% of the NBD-positive BCP fraction
(Fig. 5, B and C, SAC).
The virtually exclusive labeling of SAC in the BCP re-
gion, as accomplished by this treatment thus allowed us,
after extensive washing of the cells to remove the dithion-
ite, to investigate the subsequent fate of C6-NBD-GlcCer
and C6-NBD-SM associated with the SAC. To this end,
transport was re-activated by rewarming and further incu-
bating the cells in HBSS at 378C for various time intervals.
BSA was included in the medium to prevent re-internal-
ization of the lipid analogues from the basolateral PM and
subsequent basolateral to apical transcytosis. Over a 30-
min time span, the percentage of BCP labeled with C6-
NBD-GlcCer remained fairly constant at z90%, whereas
the percentage of C6-NBD-SM–labeled BCP decreased to
655% after 30 min (Fig. 5 A). Thus, after re-activation of
transport, C6-NBD-SM, in contrast to C6-NBD-GlcCer,
disappeared from the apical membrane region. Indeed,
while after a 30-min time interval the localization of the
remaining fraction of C6-NBD-GlcCer in the BCP com-
partments was about equally distributed between BC and
SAC (Fig. 5 B), ,25% of the remaining fraction of the C6-
NBD-SM fluorescence at the BCP was associated with
BC. Rather, nearly 80% was found to be associated with
SAC over the entire 30-min time interval (Fig. 5 C). From
these data we conclude that after re-activation of transport
of the lipid analogues from the SAC, C6-NBD-SM traffick-
ing prefers a sub-apical to basolateral direction, while C6-
NBD-GlcCer recycles from the SAC to BC thus remaining
in the apical region of the cell. Hence, the results suggest
that in the sub-apical vesicular structures C6-NBD-GlcCer
and C6-NBD-SM are sorted and flow preferentially to the
apical and basolateral membrane domains, respectively.
Sorting of Glycosphingolipid in SAC Is Highly Specific
To further determine the specificity of the sorting event in
the SAC, the trafficking of C6-NBD-GalCer was exam-
ined. Whereas C6-NBD-GlcCer and C6-NBD-SM have en-
tirely different head groups (glucose versus phosphocho-
line, respectively), C6-NBD-GlcCer and C6-NBD-GalCer
are epimers (i.e., they differ in the spatial orientation of
only one hydroxyl moiety in the carbohydrate head
group). To label the bile canalicular membrane, the cells
were labeled with C6-NBD-GalCer at 378C for 30 min and
back exchanged (according to Fig. 1, step 1 and 2). C6-
Figure 4. Sodiumdithionite reduces
BC-associated fluorescence without
getting access to SAC. Cells were la-
beled with 4 mM C6-NBD-GlcCer or
C6-NBD-SM at 378C for 30 min. The
fluorescent lipid analogues present in
the basolateral PM were then depleted
by incubating the cells twice for 30 min
in HBBS, supplemented with 5% BSA
at 48C. Cells were subsequently washed
with PBS, rewarmed, and then incu-
bated at 188C in HBSS 1 BSA for 1 h.
When the cells were subsequently
treated with 30 mM sodiumdithionite in HBSS (diluted from a 1 M stock solution in 1 M Tris/HCl, pH 10) at 48C for 7 min, C6-NBD-
GlcCer (b; a, phase contrast to b) and C6-NBD-SM (d; c, phase contrast to d) were absent from BC, while leaving the fluorescence in
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NBD-positive BCP was due to labeling of only BC) was
subsequently chased at 188C for 60 min in BSA-containing
HBSS (Fig. 1, step 3). Similar to C6-NBD-GlcCer and -SM,
C6-NBD-GalCer was found to accumulate in SAC (not
shown). Cells were then subjected to steps 4 and 5 of the
incubation scheme (Fig. 1) to examine the exiting of the
lipid analogue from the SAC. Over a 30-min time inter-
val, the percentage of C6-NBD-GalCer–labeled BCP de-
creased from 85% to 65% (Fig. 6 A). Compared with the
trafficking of C6-NBD-GlcCer and C6-NBD-SM (compare
with Fig. 5), C6-NBD-GalCer thus appeared to disappear
from the BCP, similarly as observed in the case of C6-
NBD-SM. Consistently, as reported previously for the latter
analogue, GalCer also preferentially locates to the baso-
lateral membrane, as revealed by fluorescence microscopy
(not shown; compare with Fig. 3 in van IJzendoorn et al.,
1997). Examination of the distribution of the remaining
fraction of C6-NBD-GalCer in the apical area revealed,
that the vast majority (60–70%) of this fraction resided ex-
clusively in SAC (Fig. 6 B), indicative of a lack of a sub-
Figure 5. Semi-quantitative kinetic analysis of C6-NBD-GlcCer
and C6-NBD-SM, exiting from SAC. First, the lipid analogues
were accumulated in SAC. To this end, cells were labeled with 4 mM
C6-NBD-GlcCer or C6-NBD-SM at 378C for 30 min. After deple-
tion of the fluorescent lipids from the basolateral PM by back ex-
change, the cells were subsequently incubated in HBSS 1 BSA at
188C for 60 min. To eliminate BC-associated NBD fluorescence,
cells were then treated with 30 mM sodiumdithionite at 48C for 7
min. After removal of the sodiumdithionite by extensive washing,
the temperature was shifted to 378C to reactivate transport from
SAC. In A, the percentage of BCP labeled with either lipid ana-
logue after a 0- (i.e., before the chase), 10-, 20-, and 30-min chase
is presented. In B, the distribution of the BCP-associated C6-
NBD-GlcCer is shown, and in C, that of C6-NBD-SM fluorescence,
as determined after the indicated incubation time at 378C. In A,
data are expressed as percentage of total (i.e., NBD-positive 1
NBD-negative) BCP (mean 6 SEM) of at least four independent
experiments carried out in duplicate. In B and C, data are ex-
pressed as percentage of total NBD-positive BCP (mean 6 SEM)
of at least four independent experiments, carried out in duplicate.
Figure 6. Semi-quantitative kinetic analysis of C6-NBD-GalCer,
exiting from SAC. The analogue was accumulated in SAC as fol-
lows. Cells were labeled with 4 mM C6-NBD-GalCer at 378C for
30 min to label BC. After depletion of fluorescent lipids from the
basolateral PM, the cells were subsequently incubated in HBSS 1
BSA at 188C for 60 min. Cells were then treated with 30 mM sodi-
umdithionite at 48C for 7 min to eliminate BC-associated fluores-
cence. After removal of the sodiumdithionite by extensive wash-
ing, the temperature was shifted to 378C to reactivate transport
from SAC. In A, the percentage of BCP labeled with C6-NBD-
GalCer after a 0, 10, 20 and 30 min chase is presented. In B, the
distribution of the BCP-associated C6-NBD-GalCer is shown. In
A and B, data are expressed as percentage of total (i.e., NBD-
positive 1 NBD-negative) BCP (mean 6 SEM) and of total
NBD-positive BCP of at least four independent experiments car-
ried out in duplicate, respectively.
NBD-GalCer was found to be transcytosed to the BC with
similar kinetics as those of the short chain analogues of
GlcCer and SM (not shown), implying bulk membrane
transport. BC-associated C6-NBD-GalCer (685% of thevan IJzendoorn and Hoekstra Sphingolipid Sorting in Sub-Apical Compartments 689
stantial movement of C6-NBD-GalCer toward BC, simi-
larly as observed for the SM analogue, and emphasizing
that like C6-NBD-SM, the glycolipid, after exiting SAC, dis-
appeared from the apical region of the cell. Hence, the
data indicate that C6-NBD-GalCer, like C6-NBD-SM, is
preferentially targeted from the SAC to the basolateral
PM domain and, thus, appears to be sorted in this com-
partment from C6-NBD-GlcCer.
Sorting at the Luminal Leaflet of SAC;
Transcytotic Trafficking of C6-NBD-SM and
C6-NBD-GlcCer Occurs by Vesicular Means
To further define the exclusiveness and specificity of SAC
in lipid sorting in the reverse transcytotic pathway in
HepG2 cells, it is important to establish the mechanism of
trafficking of both sphingolipids in HepG2 cells. This mecha-
nism  could involve monomeric flow or vesicle-mediated
transport or both. Monomeric flow could entail flip-flop
mechanisms across basolateral and apical membranes, me-
diated by the translocating activities (in outward direction)
of MRP1 and MDR1, respectively (van Helvoort et al.,
1996; Roelofsen et al., 1997). The evidence indicates that
the lipid pool, derived from the apical membrane and
arriving in SAC is derived from the exoplasmic leaflet of
the apical membrane. Thus, treatment of the cells before the
incubation with the lipid analogues (Fig. 1, step 1) with the
MDR1 inhibitor PSC 833, under conditions that com-
pletely blocked the expulsion of the MDR substrate
Rhodamine 123, did not affect delivery of either lipid ana-
logue to the lumenal leaflet of BC as judged by the ability
of sodiumdithionite to reduce the entire pool of BC-asso-
ciated NBD fluorescence (Fig. 7 A; compare with van
IJzendoorn et al., 1997). This implies that the analogues
reached the apical membrane by vesicular transport, the
NBD-tagged lipids residing in the inner leaflet of the ve-
sicular membrane. Note that NBD fluorescence, had it
been located in the cytoplasmic leaflet of the BC mem-
branes, in contrast to that with a lumenal orientation,
would not be accessible to quenching by sodiumdithionite
under the experimental conditions (see Materials and
Methods; compare with Fig. 4). Therefore, the presence of
any NBD fluorescence in the cytoplasmic BC leaflet re-
sulting from impaired translocator activity would have
prompted us to classify such BC as NBD-positive. Identi-
cal results were obtained when the cells had been preincu-
bated with MK 571 (compare with Fig. 7 A), a specific in-
hibitor of the function of basolaterally located MRP1,
which has been shown to partly overlap with the exclu-
sively at the BC membrane localized MDR1 (Roelofsen
et al., 1997). Thus neither MDR1 nor MRP1 were involved
in the delivery of C6-NBD-GlcCer and C6-NBD-SM to the
lumenal leaflet of BC.
It is then reasonable to assume that subsequent trans-
port from apical membrane to SAC is vesicle mediated,
delivering the exoplasmic lipids to the inner leaflet of the
SAC. Indeed, given the capacity of the analogues to
readily engage in monomeric transfer and yet, their spe-
cific retainment in SAC at 188C, the data are entirely con-
sistent with a localization that is restricted to the inner
leaflet of SAC membranes. Subsequent transport after
sorting in this compartment most likely occurred by a vesi-
cle-mediated mechanism. This was inferred from the fol-
lowing experiments. Monomeric trafficking from SAC
would have resulted in a preferential delivery of C6-NBD-
GlcCer to the cytoplasmic leaflet of the apical membrane
and of C6-NBD-SM to the corresponding leaflet of the ba-
solateral membrane. The subsequent appearance at the
exoplasmic leaflet would then require translocation via
MDR1 and MRP1, respectively. To investigate whether
any fraction of the lipid analogues that had left the apical
membrane could reach the inner leaflet of the basolateral
PM, and thus become susceptible to translocation by
MRP1, cells were first incubated according to steps 1 and 2
(see Fig. 1). MK 571 was added during step 2. The cells
were then rewarmed to 378C and further incubated in
HBSS, supplemented with BSA and MK 571 for 1 h. As
shown in Fig. 7 B, the fraction of lipid analogues that could
be back exchanged from the basolateral surface was simi-
lar to that of non-treated cells. Subsequently, we examined
transport of SAC-accumulated lipids. Thus, the cells were
treated subsequent to step 4 (i.e., before chasing the lipid
analogues from the SAC), with either PSC 833 or MK 571.
However, in neither case did the treatment affect the pref-
erential trafficking of C6-NBD-GlcCer and C6-NBD-SM
Figure 7. Multi-drug resistance proteins, MDR1 and MRP1, do
not affect C6-NBD-lipid arrival at the PM domains. In A, cells
were preincubated with PSC 833 (5 mg/ml) at 378C for 30 min be-
fore step 1 (see Fig. 1). In the presence of the drug, the cells were
then labeled with lipid analogues at 378C for 30 min. The cells
were subsequently subjected to a back exchange (step 2 of Fig. 1)
and the percentage of NBD-positive BC was determined (white
bars). Alternatively, cells were subsequently treated with 30 mM
dithionite and the percentage of NBD-positive BC was deter-
mined (hatched bars). In B, cells were incubated with either lipid
analogue at 378C for 30 min and back exchanged at 48C twice for
30 min. Then, cells were rewarmed to 378C and incubated for 1 h
in back exchange medium. Lipids were extracted from the back
exchange media and cell fractions to determine the percentage
back exchangeable C6-NBD-lipid. Data are expressed as mean 6
SEM of at least two independent experiments.The Journal of Cell Biology, Volume 142, 1998 690
to the apical or basolateral PM domain, respectively (com-
pare with Fig. 5). Taken together, the results indicate that
C6-NBD-SM and C6-NBD-GlcCer were not used as a sub-
strate for the multi-drug resistance proteins at either PM
domain and therefore must have been residing in the lu-
menal leaflet of vesicular compartments during all trans-
port steps. Hence, the observed sorting of C6-NBD-SM
and C6-NBD-GlcCer must have been restricted to the lu-
menal leaflet of the SAC.
Transcytosing pIgR-IgA Colocalizes with Apically 
Derived C6-NBD-Sphingolipids in the SAC
In MDCK cells, SAC (also referred to as ARC) have been
described that are part of the transcytotic pathway, as re-
vealed by the trafficking of the pIgR-IgA receptor–ligand
complex, an established transcytotic marker (Apodaca
et al., 1994; Barosso and Sztul, 1994). To further define the
identity of the SAC through which both C6-NBD-SM and
C6-NBD-GlcCer pass, the intracellular trafficking of fluo-
rescently labeled IgA in HepG2 was examined, and re-
lated to that of the lipid analogues. HepG2 cells do not en-
dogenously express the pIgR. Consistently, we were unable
to detect pIgR by indirect immunofluorescence using an
anti-pIgR mAb (not shown). However, some internaliza-
tion of TxR-IgA was observed. Yet, this uptake could be
completely abolished by adding excess asialofetuin (not
shown), indicating that in HepG2 cells IgA can presum-
ably also become internalized by the asialoglycoprotein
receptor, consistent with previous observations (Tomana
et al., 1988). We therefore stably transfected HepG2 cells
with the pIgR (see Materials and Methods), which at
steady-state was distributed throughout the cytoplasm
with a preference for the apical region of the cell, and
monitored the internalization of IgA in the presence of ex-
cess asialofetuin. When cells were incubated with 50 mg/ml
TxR-IgA at 48C for 30 min, washed, and then incubated at
378C for short time intervals only (20 min or less), a sub-
stantial fraction of the intracellular fluorescence could al-
ready be detected in SAC (Fig. 8 a). Prolonged incuba-
tions at 378C (Fig. 8 b), but not 188C (Fig. 8 c), resulted in a
pronounced labeling of BC, indicating that pIgR-IgA trav-
eled through SAC before being delivered to BC. More-
over, the delivery of sub-apically located pIgR-IgA to BC
was impaired at 188C. To determine whether the TxR-
IgA–labeled SAC were the same as those in which apically
derived lipid analogues were found to accumulate (i.e.,
SAC [see Fig. 2, d and f]), cells were incubated with TxR-
IgA at 48C for 30 min, washed, and then incubated with
C6-NBD-SM at 378C, allowing both compounds to enter
the cells. After a back exchange of the fluorescent lipid
pool associated with the basolateral PM (see Fig. 1, step 2),
C6-NBD-SM was found to label intracellular vesicular
structures and BC (compare with Fig. 2, c and d; van
IJzendoorn et al., 1997). Note that pretreatment with ex-
cess asialofetuin did not affect uptake and intracellular lo-
calization of the lipid analogue (not shown). In the same
cells, TxR-IgA was detected in both BC and vesicular
structures located near the BC (Fig. 8 a). The cells, thus
containing intracellular pools of IgA and sphingolipid,
were subsequently incubated at 188C for 1 h to allow api-
cally derived lipid analogues to accumulate in SAC as de-
scribed above. Interestingly, as evidenced by confocal la-
ser scanning microscopy, TxR-IgA distribution displayed a
substantial overlap with C6-NBD-SM in the SAC (Fig. 8,
d–g, arrows). Similar results were obtained with C6-NBD-
GlcCer and C6-NBD-GalCer (not shown). Note that the
data in Fig. 8 demonstrate a colocalization of lipid and
IgA, particularly in the prominently present SAC. Some
differences in localization of lipid analogue and IgA can
be readily explained by the notion that the lipid is trans-
ported from BC to SAC, whereas IgA enters SAC, arriv-
ing from the basolateral membrane. Also, the fate of the
subsequent flow differs, SM traveling to the basolateral
Figure 8. Transcytosing IgA and NBD-
labeled sphingolipids colocalize in SAC in
HepG2 cells. Asialofetuin-pretreated
cells were labeled with 50 mg/ml TxR-IgA
at 48C for 30 min, washed, and then incu-
bated at 378C for 20 min in HBSS (a). The
cells were further incubated at 378C for
another 30 min (b) or alternatively,
cooled to 188C and further incubated at
this temperature for 60 min (c). In d–g,
confocal images of the BC area, labeled
with C6-NBD-lipid (d and f) or TxR-IgA
(e and g) are shown (f and g, x-z sections
of d and e, respectively). Note the similar-
ity in the shape of the fluorescence pat-
tern obtained for accumulating protein
and lipid, adjacent to the BC (arrows).
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membrane, whereas IgA travels to the apical membrane
(see also Discussion). In conclusion, the results indicate
that the sorting compartment for simple monohexoyl-
sphingolipids in the reverse transcytotic pathway in
HepG2 cells, SAC, displays the same identity as pIgR-IgA–
accumulating compartments identified in MDCK as ARC.
Transport of Apically Derived C6-NBD-GlcCer
and -SM to SAC, but Not Apical
Endocytosis of C6-NBD-GlcCer and -SM Is
Affected by Nocodazole
The aforementioned results indicate that the mechanism
of sphingolipid trafficking between apical membrane and
SAC, is accomplished by vesicular transport. Many vesicu-
lar transport events appear to require an intact microtu-
bule network. To investigate the involvement of microtu-
bules in transport between the apical PM and the SAC,
cells were incubated with C6-NBD-SM or -GlcCer at 378C
for 30 min, after which the pool of fluorescent lipid ana-
logues in the basolateral PM was depleted with BSA (Fig.
1, step 1 and 2). During this back exchange procedure 33 mM
nocodazole was included, a concentration sufficient to dis-
rupt microtubules as revealed by immunofluorescence us-
ing a mAb directed against b-tubulin (not shown). After
extensive washing, the cells were incubated at 188C and
BC-associated lipid analogues were chased in back ex-
change medium (HBSS 1 5% BSA), supplemented with
nocodazole for 1 h. Internalization of either lipid analogue
from the apical PM was not inhibited by nocodazole, as
judged by the similarities in the decrease of the percentage
of NBD-labeled BC, when compared with non-treated
cells (Table I). However, whereas in non-treated cells, in-
tensely labeled SAC was observed after a 1-h chase at
188C (Fig. 2, d and f), in nocodazole-treated cells the label-
ing of SAC was conspicuously absent. Rather, numerous
small vesicular structures, labeled with either C6-NBD-SM
or -GlcCer, were seen, distributed throughout the cyto-
plasm (Fig. 9, a–d). The effect of nocodazole was revers-
ible, and C6-NBD-GlcCer– and -SM–labeled SAC ap-
peared after a prolonged incubation in nocodazole-free
medium (Fig. 9, c and f, arrows). Concomitantly, immu-
nofluorescence experiments to visualize b-tubulin (as de-
scribed above) revealed that intact microtubules reap-
peared during this prolonged incubation (not shown).
Previously, it was demonstrated that the organization of
the sub-apical compartments (ARC) as described in
MDCK cells requires an intact microtubule network.
Thus, whereas the SAC in control cells were concentrated
in a centralized spot, they were found to be dispersed
throughout the apical cytoplasm in the nocodazole-treated
cells (Apodaca et al., 1994). To investigate whether the or-
ganization of the SAC, as shown in Figs. 2 (d and f) and 4,
was also dependent on intact microtubules, SAC were first
pre-loaded with either lipid analogue by chasing BC-asso-
ciated lipid at 188C for 1 h as described above. After
quenching of label in BC with dithionite (Fig. 1, step 4),
the cells were incubated in nocodazole-containing HBSS
at 48C or 188C for 1 h. Although the microtubule organiza-
tion was effectively disrupted at either condition (see
above), nocodazole did not change the appearance of la-
beled SAC, implying that their appearance was indistin-
guishable from that in non-treated cells (Fig. 10, a and b).
However, under identical experimental conditions, no-
codazole was found to be effective in disrupting C6-NBD-
Cer–preloaded Golgi apparatus (Fig. 10, c and d; Turner
and Tartakoff, 1989). The results thus indicate that rather
than (early) apical endocytosis or the organization of the
Figure 9. Nocodazole prevents accumula-
tion of C6-NBD-lipids in the SAC. Cells
were labeled and treated according to
steps 1 and 2 of Fig. 1. During step 2, 33
mM nocodazole was included to disrupt
the cell its microtubules. In the presence
of nocodazole, the cells were then incu-
bated at 188C for 1 h in back exchange
medium, washed, and then photographed.
Note the absence of accumulation of C6-
NBD-SM (b; a, phase contrast to b) and
C6-NBD-GlcCer (e; d, phase contrast to e)
in the sub-apical area (for control, see Fig.
2). Sub-apical labeling reappeared after a
prolonged incubation in back exchange
medium at 378C for 60 min, in the absence
of nocodazole (arrows: c, C6-NBD-SM; f,
C6-NBD-GlcCer). Bar, 10 mm.
Table I. Effect of Nocodazole on the Disappearance of
C6-NBD-SM and C6-NBD-GlcCer from BC 
Percent of NBD-positive BC
C6-NBD-GlcCer C6-NBD-SM
Before chase 100 100
After chase
control 61 6 5 59 6 4
nocodazole 58 6 2 57 6 3
Cells were incubated with C6-NBD-GlcCer or -SM at 378C for 30 min. The fluo-
rescent pool of C6-NBD-lipids in the basolateral PM was then back exchanged
in the absence or presence of nocodazole. Cells were then rewarmed to and fur-
ther incubated in back exchange medium with or without nocodazole at 188C
for 1 h. The percentage of NBD-positive BC (i.e., BC alone and BC 1 SAC)
was determined as described in Materials and Methods. The percentage of
NBD-positive BC before the chase was set at 100%. Data are expressed as
mean 6 SEM of at least two independent experiments.The Journal of Cell Biology, Volume 142, 1998 692
SAC, (a) distinct transport step(s) after endocytic internal-
ization, but before the delivery to SAC, is dependent on
intact microtubules.
Discussion
In polarized HepG2 cells, the sphingolipid analogues
C6-NBD-GlcCer and C6-NBD-SM display a preferential
plasma membrane localization, the GlcCer derivative ac-
cumulating primarily at the apical membrane, while the
SM derivative prefers the basolateral membrane (van
IJzendoorn et al., 1997). The mechanism underlying this
preferential distribution involves their internalization
from the apical, BC surface. For the trafficking of GlcCer,
a tentative role for a non-Golgi–related compartment was
proposed. In the present study, we have established the
identity of these compartments and their functional in-
volvement in determining the distinct fate of several sphin-
golipids in the apical to basolateral pathway. Furthermore,
the data demonstrate that the processing of C6-NBD-
GlcCer and C6-NBD-SM in HepG2 cells is accomplished
by vesicular transport and that the preferential localiza-
tion in either plasma membrane domain is not mediated
by interference of multi-drug resistance proteins, which
have been reported to display the ability to translocate
lipid analogues from inner to outer leaflet across plasma
membranes (van Helvoort et al., 1997). Rather, after hav-
ing reached the apical membrane by transcytosis, after ini-
tial insertion in the basolateral membrane, the lipid ana-
logues were transported from the BC toward SAC, where
they accumulate at low (188C) temperature, reflecting a
temperature-sensitive step in the exit of the lipids from
this compartment. In Fig. 11, a model depicting the central
involvement of SAC in apical to basolateral transcytosis of
sphingolipids in HepG2 cells is presented. In this figure,
transport of the sphingolipids from BC to SAC is repre-
sented by steps 1 and 2. Transport to the SAC is microtu-
bule dependent (Fig. 11, step 2) and represents a direct
pathway, i.e., it does not involve trafficking via the baso-
lateral PM, as the presence of BSA in the incubation me-
dium precludes any re-uptake and subsequent trafficking
of the lipids back to the apical pole. The results indicate that
SAC constitute an intrinsic part of the apical to basolateral
transcytotic pathway through which (glyco)sphingolipids
traverse the cells, bearing reminiscence of a sub-apical
compartment, previously identified as ARC in polarized
protein transport in MDCK cells (Apodaca et al., 1994;
Barosso and Sztul, 1994). However, an important distinc-
tion between both compartments is that the structural or-
ganization of ARC depends on an intact microtubule sys-
tem, in marked contrast to SAC, the integrity of which
does not depend on microtubules. In this Golgi-unrelated
compartment, lipid sorting occurs, implying that GlcCer is
Figure 10. Nocodazole does not affect the spatial organization of
SAC but perturbs the organization of the Golgi apparatus. In a
and b, cells were labeled with C6-NBD-GlcCer according to steps
1–4 of Fig. 1, to label SAC. In b, cells were subsequently incu-
bated with 33 mM nocodazole at 48C for 60 min. Note that no-
codazole does not affect the appearance of the NBD lipid–labeled
SAC. This was also the case when the nocodazole-treatment was
done at elevated temperatures (van IJzendoorn, S.C.D., and D.
Hoekstra, unpublished observations). In c and d, cells were la-
beled with 4 mM C6-NBD-Cer at 48C for 30 min, washed, and
then incubated in back exchange medium at room temperature
for 20 min. A typical Golgi apparatus labeling pattern was ob-
tained (c). In parallel, such Golgi-labeled cells were subsequently
treated with 33 mM nocodazole at 48C for 60 min (d). Note the
clearly different fluorescence pattern in the nocodazole-treated
cells. Bar, 5 mm.
Figure 11. The role of SAC
in the trafficking/sorting of
sphingolipids in the apical to
basolateral transcytotic path-
way in HepG2 cells. C6-NBD-
sphingolipids are endocytosed
from the apical, bile canalicu-
lar plasma membrane (step
1) and transported to SAC
via a route of which at least
part is microtubule depen-
dent (step 2). Exit from the
SAC (step 3) appears to be
temperature dependent as it
can be blocked at 188C. Note that the spatial organization of SAC
does not require an intact microtubule network (see text). In the
SAC, presumably within its lumenal leaflet, the sphingolipids are
sorted, followed by vesicular transport of C6-NBD-GlcCer, pref-
erentially to the apical plasma membrane domain, and of C6-
NBD-SM and C6-NBD-GalCer, preferentially to the basolateral
plasma membrane domain (step 3). SAC, sub-apical compart-
ments; BC, bile canalicular plasma membrane; N, nucleus; G,
Golgi apparatus; TJ, tight junctional complex.van IJzendoorn and Hoekstra Sphingolipid Sorting in Sub-Apical Compartments 693
recycled to the apical membrane, whereas NBD deriva-
tives from SM and GalCer are processed by vesicular
transport to the basolateral membrane (Fig. 11, step 3).
Hence, SAC appear to play a prominent role in maintain-
ing lipid polarity in polarized hepatic cells.
Characteristics of the SAC
The identity of SAC as a compartment specifically associ-
ated with the transcytotic pathway in HepG2 cells, is sup-
ported by the observation that the transcytotic marker
IgA/pIgR traverses this compartment in a temperature-
dependent manner. In polarized MDCK cells, its validity
as a transcytotic marker has been demonstrated, and low
temperature inhibits transcytosis of receptor-bound IgA
by an impaired exit of this receptor–ligand complex from
structures located near the apical PM, i.e., ARCs. Indeed,
inhibitory effects of low temperature on transcytotic trans-
port of proteins in polarized cells, without affecting en-
docytosis, have been shown before (Maratos-Flier, 1987;
Breitfeld et al., 1989; Hunziker and Mellman, 1989; Apo-
daca et al., 1994; Barosso and Sztul, 1994). Moreover, IgA-
and transcytosing pIgR–containing vesicular structures lo-
cated subjacent the apical PM have been described in rat
hepatic cells (Hoppe et al., 1985; Barr and Hubbard, 1993;
Geuze et al., 1984; Hemery et al., 1996) and in polarized
WIF-B cells (Ihrke et al., 1998). HepG2 cells are of human
origin and do not express the pIgR. Expression was ac-
complished however by transfection and transfected
HepG2 cells were found to internalize TxR-IgA, which
was rapidly transported to the apical pole (Fig. 8 a), con-
sistent with the anticipated fate of a transcytotic marker.
Interestingly, whereas intense labeling of BC was ob-
served after longer incubations at 378C (Fig. 8 b), TxR-
IgA was not fully transcytosed to the apical surface at 188C
but accumulated in SAC instead. Since TxR-IgA was ob-
served in SAC before it appeared in the BC, the data sug-
gest that SAC-associated TxR-IgA originated directly
from the basolateral area rather than from the apical PM
from which IgA (at least in rat hepatocytes) can be inter-
nalized (Jones et al., 1984). This conclusion is entirely
compatible with the fate of pIgR in hepatic WIF-B cells
(Ihrke et al., 1998). Importantly, apically derived C6-NBD-
lipids were found to colocalize with transcytosing TxR-
IgA in the SAC (Fig. 8, d vs. e, and f vs. g). Remarkably, in
contrast to apically derived C6-NBD-lipids, which were
found to colocalize with transcytosing TxR-IgA in SAC
(Fig. 8, d–g), basolaterally derived lipid was far less promi-
nently trapped in SAC at 188C. As demonstrated before,
basolateral to apical trafficking of the sphingolipids pro-
ceeds by bulk flow, whereas segregation is seen in the api-
cal to basolateral pathway (van IJzendoorn et al., 1997).
The appreciation of the involvement of SAC in apically di-
rected bulk flow trafficking of the lipid analogues there-
fore remains to be determined. The data emphasize how-
ever the involvement of SAC as a sorting compartment in
the segregation of the lipids, as occurs in the reverse path-
way. Thus, the striking similarity with respect to the intra-
cellular (sub-apical) localization and the temperature-
dependent characteristics concerning the trafficking of
IgA via these compartments supports the view, that the
lipid-labeled SAC in HepG2 cells and the ARC in MDCK
cells are analogous. Ihrke et al. (1998) proposed that SAC
in hepatic WIF-B cells are mainly a one-way sorting sta-
tion in the basolateral to apical pathway, as they were un-
able to detect recycling resident apical proteins in similar
SAC by biochemical means (Barr and Hubbard, 1993; Barr
et al., 1995). However, our experiments, in which we are
able to directly monitor the endocytic flow of apical mem-
brane in living cells, indicate that the transcytotic traffick-
ing pathways between apical and basolateral membranes
and vice versa do appear to merge in SAC. The relation-
ship between lipid and protein traffic via these compart-
ments is clearly an important issue that needs to be ad-
dressed in future studies.
Golgi markers are excluded from the apical recycling
compartments in MDCK cells, and an (apical) endosomal
nature of the compartment was proposed (Apodaca et al.,
1994). Two pieces of evidence indicate that also in HepG2
cells SAC appear to be unrelated to the Golgi apparatus.
First, whereas monensin inhibits sphingolipid transport from
the Golgi-apparatus to BC in HepG2 cells (van IJzen-
doorn et al., 1997) as well as to the PM in non-polarized
cells (Lipsky and Pagano, 1985; Kok et al., 1992), apical to
basolateral transcytosis of C6-NBD-GlcCer and C6-NBD-
SM in HepG2 cells is unaffected by this treatment. Second,
treatment of the cells with nocodazole, a microtubule-dis-
rupting compound, clearly affected the morphology of the
Golgi apparatus, but had no visible effect on the morphol-
ogy of SAC preloaded with fluorescent lipid analogue
(Fig. 10). Intriguingly however, this very feature distin-
guishes SAC from ARC in MDCK cells in that the integ-
rity of the latter entirely depends on an intact microtubu-
lar organization (Apodaca et al., 1994).
Interestingly, nocodazole inhibited transport of lipid an-
alogues from BC to SAC (Fig. 9), but not apical endocyto-
sis (Table I; Fig. 11, steps 1 and 2). Transport of proteins
and lipids from the PM to early “sorting” endosomes is
typically microtubule-independent (Hunziker et al., 1990;
Matter et al., 1990; Kok et al., 1992). By contrast, transport
of proteins and lipids from such early sorting endosomes
to a functionally and morphologically distinct set of endo-
somal compartments located in the perinuclear region
(Gruenberg and Maxfield, 1995) requires an intact micro-
tubule network (Gruenberg et al., 1989; Hunziker et al.,
1990; Kok et al., 1992). Moreover, the ARC appears to
share a striking homology with the perinuclear recycling
endosome, described in non-polarized cells (Zacchi et al.,
1998). These features also seem to hold for the present sys-
tem, when comparing the localization of lipid analogues
and pIgR in polarized and non-polarized HepG2 cells
(Fig. 2, see below). Hence, in conjunction with its localiza-
tion in the juxtanuclear/Golgi area facing the apical PM
(Gruenberg and Maxfield, 1995), SAC thus bear reminis-
cence to a recycling endosomal compartment rather than
to an early sorting endosome, correlating with the pericen-
triolar localization of recycling endosomes in other polar-
ized cells (Hughson and Hopkins, 1990). Obviously, a de-
tailed characterization of the localization of specific
markers (e.g., mannose-6-phosphate receptor; different
rab proteins, etc.) will be required to obtain further insight
into the exact nature of this compartment. However, given
that apical membrane derived lipid analogues and basolat-
eral membrane derived IgA are both delivered to SACThe Journal of Cell Biology, Volume 142, 1998 694
(Fig. 8), it would thus appear that the compartment acts as
a “traffic center” in (reverse) transcytotic trafficking in po-
larized cells. Fully compatible with this conclusion is a pre-
vious hypothesis that pathways originating from the apical
and basolateral pathways merge at a perinuclear endoso-
mal compartment that is distinct from early (sorting) en-
dosomes in polarized cells (Parton et al., 1989; Hughes and
Hopkins, 1990).
Intriguingly, accumulation of the lipid analogues and
IgA was also observed in non-polarized HepG2 cells, i.e.,
cells that had not formed an apical, biliary PM domain.
This accumulation was typically in the juxtanuclear area of
the cells (Fig. 2, wide arrows), and was abolished in no-
codazole-pretreated cells (Fig. 9), similarly as observed for
sphingolipid transport from early to perinuclear endo-
somes in non-polarized BHK cells (Kok et al., 1992).
These observations underscore that SAC is not a unique
compartment, but rather that its specific functional fea-
tures, including sorting in (reverse) transcytosis, are be-
coming apparent only in polarized cells. Indeed, after sub-
mission of this manuscript, Zacchi et al. (1998) reported
that rab17, a small GTPase that has been shown to be in-
duced upon cell polarization (Lütcke et al., 1993), associates
with both the ARC in polarized cells and the perinuclear
recycling endosome when expressed in non-polarized cells.
Sorting of Sphingolipids in SAC
After treatment with sodiumdithionite, NBD fluorescence
in BC, but not in SAC, was nearly completely eliminated
(Figs. 4 and 5, B and C, 0 min; compare with van IJzen-
doorn et al., 1997). This approach thus allows to monitor
subsequently the fate of the lipid analogues that have ac-
cumulated into SAC (at 188C). Indeed, after a 30-min
chase at 378C, the extent of BCP labeling with C6-NBD-SM
or C6-NBD-GalCer had decreased by .30% and 20%, re-
spectively, compared with that with C6-NBD-GlcCer (Figs. 5
A and 6 A). This indicated that C6-NBD-SM and C6-NBD-
GalCer, relative to C6-NBD-GlcCer, were transported out
of the bile canalicular region (Fig. 5 A and 6 A). Indeed,
whereas the fractions of both SM and GalCer that re-
mained in the BCP area were primarily restricted to SAC,
that of GlcCer showed a different fate. Not only did the
latter lipid show a strong preference for a localization in
the apical region of the cell, as reflected by the fact that
z90% of the BCP remained labeled with this lipid during
a chase of at least 30 min, there was also an apparent trend
of its time-dependent translocation from SAC to the BC.
Evidently, these kinetic changes in pool size and BCP lo-
calization (SAC versus BC) are entirely consistent with
the preferential localization of GlcCer in the apical and
that of SM in the basolateral region of the cell (van IJzen-
doorn et al., 1997). Here, we show that GalCer also shows
a distinct preference for a basolateral localization, al-
though less pronounced than SM. The results indicate that
SAC determine the subsequent fate of the lipid analogues,
involving their flow from the SAC to preferential PM do-
mains, and implying that sorting occurs in these compart-
ments.
Presumably, segregation of the sphingolipids takes place
within the lumenal leaflet of the SAC, since inhibitors of
MDR1/P-glycoprotein and MRP1, previously shown to be
able to translocate C6-NBD-lipids over the PM (van Hel-
voort et al., 1996), did not affect the outcome of the exper-
iments (Fig. 7). Hence, monomeric trafficking to the inner
leaflet of either plasma membrane, followed by outward
translocation by either MDR1 or MRP1, can be excluded.
Thus, a highly specific sorting event, given the remarkable
distinction that becomes apparent in the sorting of GlcCer
and its epimer, GalCer, and vesicular packaging underlie
the overall processing of the lipid analogues by SAC. In
this context it is interesting to mention that the calmodulin
antagonist W7 appears to have distinct effects on the traf-
ficking of C6-NBD-GlcCer and C6-NBD-SM from the
SAC, thus supporting the proposed model in which
GlcCer and SM are segregated into distinct pools within
the SAC membranes, which can be separately recognized
by mechanisms that regulate trafficking (van IJzendoorn,
S.C.D., and D. Hoekstra, unpublished results).
In the biosynthetic pathway, apical sorting in polarized
cells has mainly focused on a mechanism involving target-
ing of glycosphingolipid-enriched clusters or rafts, origi-
nating from the TGN (Simons and Ikonen, 1997; Weimbs
et al., 1997). In addition, glycosphingolipid-enriched rafts
were also postulated to be involved in endocytotic and
transcytotic transport routes, mediated by caveolae. In the
present study, we present for the first time evidence that
clearly indicates a role for a non-Golgi–related intracellu-
lar compartment in the sorting and, consequently, polar-
ized distribution of sphingolipids. However, the ubiquity
of this phenomenon remains to be determined, the site
and extent of sorting being dependent on cell type and na-
ture of transport route (biosynthetic pathway, basolateral
to apical membrane flow, i.e., transcytosis, or the reverse
pathway). For example, sphingolipid sorting in the trans-
cytotic pathway could not be demonstrated in MDCK cells
(van Genderen and van Meer, 1995). Possibly, sorting of
sphingolipids in this pathway is restricted to hepatic cells,
which are thought to rely heavily on transcytosis for the
correct targeting and delivery of apical proteins (Bartles et
al., 1987; Schell et al., 1992). It is yet of interest however,
that in MDCK cells, C6-NBD-GlcCer and C6-NBD-SM,
endocytosed from either PM domain reach the apical recy-
cling compartments, where they colocalize with the IgA/
pIgR complex, before delivery to the opposite surface
(van IJzendoorn, S.C.D., K.E. Mostov, and D. Hoekstra,
manuscript in preparation). In MDCK cells, sorting of
newly synthesized sphingolipids is believed to occur pre-
dominantly in the biosynthetic pathway and the actual
sorting compartment was proposed to be the TGN (Si-
mons and van Meer, 1988). Although newly synthesized
C6-NBD-GlcCer and C6-NBD-SM can be directly trans-
ported to either PM domain in HepG2 cells (Zaal et al.,
1994; Zegers and Hoekstra, 1997), sorting of sphingolipids
has not been demonstrated in hepatic cells yet. Also, the
direct Golgi to apical transport pathway is poorly charac-
terized and the intriguing question remains as to whether
SAC are part of this route in HepG2 cells. Further re-
search is imperative for a better understanding of the func-
tional involvement of the SAC/ARCs in the different po-
larized cell types with respect to lipid trafficking in distinct
transport routes as well as the integration of lipid and pro-
tein trafficking. Such work is currently in progress in our
laboratory. The identification in HepG2 cells of a non-van IJzendoorn and Hoekstra Sphingolipid Sorting in Sub-Apical Compartments 695
Golgi–related intracellular compartment, SAC, that is in-
volved in the trafficking and sorting of sphingolipids and,
moreover, its similarity to the ARC in MDCK cells (Apo-
daca et al., 1994), will be of great importance to further re-
veal and understand mechanisms underlying the genera-
tion and maintenance of membrane polarity.
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